Opioid Case Studies: Putting Theory into Practice David A. Cooke, MD, FACP University of Michigan Health System Departments of Internal Medicine and Anesthesia.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
PERSECTIVES ON OPIOID TREATMENT OF CHRONIC PAIN Jane C Ballantyne MD FRCA University of Washington School of Medicine Seattle, WA USA.
Case Presentation Lance C. Brunner M.D. Assistant Clinical Chief Department of Family Medicine.
Innovative Approach of Managing High Risk Chronic Opioid Users in a Residency Practice Erin Inglis, MD a, Jessie Burch, PharmD b, Nida Awadallah, MD c,,
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Pain Morning Report Robin Staib, PharmD December 22, 2011.
Opioid Induced Neurotoxicity
How To Prescribe Pain Medications Without Killing People Catherine Casey MD.
Palliative Care Focus on Suffering instead of pain Bernard P Sweeney, MD Medical Director, Teresa House Geneseo, NY.
Sublingual Buprenorphine and Pain
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2010.
MaineCare & Opioid Treatment Where we are… How we got here… Where we are going… Kevin S. Flanigan, MD Medical Director Office of MaineCare Services.
Chronic Opiate Therapy Benjamin Meeks, FNP. Agenda History of Opiate Therapy Risks of Opiate Therapy Benefits of Opiate Therapy Guidelines for Opiate.
Mechanical Low Back Pain (PEN) Case 2: Sudha.
MANAGING FATIGUE during treatment Since fatigue is the most common symptom in people receiving chemotherapy, patients should learn ways to manage the fatigue.
Clinical Case Studies Developed by Dr. David Hunt.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
The Pains of Chronic Opioid Usage
Pain management for AKT NICE guidelines: Neuropathic pain Opioid conversion Controlled drugs.
DOUGHNUTSDOUGHNUTS. Opioid Agonist Therapy The Skinny on Methadone et al.
Ken Saffier, MD, Natasha Pinto, MD And Patients CCRMC/HC Noon Conference February 18, 2010.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
 72 M, acute femoral fracture. History of hip, knee OA. Uses Tylenol, ibuprofen.  Used Norco in the past very infrequently. Keeps an old bottle in the.
Introduction: Medical Psychology and Border Areas
Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
Use of Opioids fro Chronic Pain in Primary Care Norman Wetterau MD
Opioids Unless otherwise indicated, the answers are from DSM-IV-TR and APA Practice Guidelines, AJP Supplement, August, As of 3Aug06.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
Addiction and dependence Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
Managing Chronic Pain Clinical Pearls and Practical Tools Dan Berland, MD, ABAM, FACP Departments of Medicine and Anesthesiology.
Opioid Tapering Paul Coelho, MD David Tauben, MD Melissa Weimer, DO, MCR.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Opioids Tapering Melissa B. Weimer, DO, MCR. Disclosures Dr. Weimer is a consultant for INFORMed, IMPACT education, and the American Association of Addiction.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Chiropractic & Pain Case Studies
Medications for Spine Pain
Current Concepts in Pain Management
Documentation of pharmaceutical care
Controlled Substances in Primary Care: An Overview of the Issues, Challenges and Management Strategies Jeff Reiter, PhD, ABPP.
Opioids for the management chronic non-cancer pain in Primary Care:
Larry Halverson, MD Gabrielle Curtis, MD Cox FMR Springfield MO
Medication-Assisted Therapy at Coleman Profession Services
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
Palliative Care in the Outpatient Setting: Pain Management
Case Presentations.
STOP! Safe Treatment of Pain
Opioid Prescribing & Monitoring
Pain Management: Patients Maintained on Buprenorphine
Challenging Cases: Part I
Supported in part by Arkansas Blue Cross and Blue Shield
Calculating and Using Morphine Equivalent Doses of Opioids
Essentials of Good Pain Care: A Team-Based Approach
The Human Body.
The Silent Killer in America
Tapering and Discontinuing Chronic Opioid Therapy
Pain Management JEFFREY TAN HO, D.O.
Presentation transcript:

Opioid Case Studies: Putting Theory into Practice David A. Cooke, MD, FACP University of Michigan Health System Departments of Internal Medicine and Anesthesia

Dr. Cooke has no financial interests relevant to this presentation. He has no relationships to the makers of any drugs discussed in his talks.

Many thanks to Dr. Daniel Berland for his assistance and material contributed to this presentation

Case 1 45 y/o man new to you, his former doc, Dr. Feelgood, recently “left practice” and he will soon need refills. History of fairly good health, but chronic headaches, neck pain and spasms 5 years after a MVA. No hx surgery or PT. Pain managed well on meds. He works part- time, smokes cigarettes. Asking for Soma 350 mg – 1 TID, OxyContin 80 mg BID and Vicodin 5/500 – 2 QID. Exam – NAD, friendly, non-specific exam.

What would you do for him at this first visit? A)Prescribe the medications so that he doesn’t go through withdrawal. B)Prescribe the OxyContin, but not Soma. C)I would tell him “I don’t kiss on the first date.” D)I would rotate his opioids to methadone.

What would you do for him at this first visit? A)Prescribe the medications so that he doesn’t go through withdrawal. B)Prescribe the OxyContin, but not Soma. C)I would tell him “I don’t kiss on the first date.” D)I would rotate his opioids to methadone.

Before that first kiss: 1) Check MAPS. 2) Check urine toxicology. 3) Check records. 4) Establish use agreement and expectations.

Current Regimen: Soma 350 mg – 1 TID OxyContin 80 mg BID Vicodin 5/500 – 2 QID

Which of the following is true? A) Soma is functionally a barbiturate, and is commonly abused. B) Soma has been proven effective for treatment of ACUTE back pain. C) Soma has been proven effective for treatment of CHRONIC back pain. D) B and C

Which of the following is true? A) Soma is functionally a barbiturate, and is commonly abused. B) Soma has been proven effective for treatment of ACUTE back pain. C) Soma has been proven effective for treatment of CHRONIC back pain. D) B and C

Current Regimen: Soma 350 mg – 1 TID OxyContin 80 mg BID Vicodin 5/500 – 2 QID

Which of the following are true? A) Oxycontin provides superior pain control, relative to other long-acting opiates. B) Oxycontin is cost-effective relative to other long-acting opiates C) Oxycontin is a preferred long-acting opiate per the UM Chronic Pain guideline D) B and C E) None of the above

Which of the following are true? A) Oxycontin provides superior pain control, relative to other long-acting opiates. B) Oxycontin is cost-effective relative to other long-acting opiates C) Oxycontin is a preferred long-acting opiate per the UM Chronic Pain guideline D) B and C E) None of the above

Monthly cost of opiates Morphine ER 60 mg BID – $51.83 Fentanyl ER 50 mEq/hr – $ Methadone 5 mg TID – $13.58 Oxycontin 40 mg BID – $ Drug prices 3/2013 at UMMC pharmacies

What is the street value for the monthly supply of his OC 80 mg #60, Vic 5 #120 ? A)$ 240 B)$ 900 C)$ 1,800 D) $ 3,400

What is the street value for the monthly supply of his OC 80 mg #60, Vic 5 #120 ? A)$ 240 B)$ 900 C)$ 1,800 D) $ 3,400

Current Regimen: Soma 350 mg – 1 TID OxyContin 80 mg BID Vicodin 5/500 – 2 QID

“Breakthrough Pain” in Chronic Pain A) is common, and patients should have PRN doses of short-acting opiates B) is indicative of medication abuse C) may not exist D) should not require more than 5-10 PRN doses per month E) C and D

“Breakthrough Pain” in Chronic Pain A) is common, and patients should have PRN doses of short-acting opiates B) is indicative of medication abuse C) may not exist D) should not require more than 5-10 PRN doses per month E) C and D

Before you commit: Is he really benefitting from the meds? Level of function? Any evidence of medication toxicity? Why no non-medication therapies? Psychological issues?

Next Steps? Stop Soma Consolidate opiates; don’t prescribe scheduled Oxycontin + Vicodin Enroll in PT Slow medication taper; MAXIMUM of 120 mg/day morphine equivalent Continue to monitor frequently

Case 2 44 y/o M with a history of low back pain radiating to left leg, present since motorbike injury at age 24. On opiates for approximately 20 years; now taking methadone 60 mg QID. PMH significant for depression, anxiety, and substance abuse; denies current drug use. Unemployed, lives with parents. No hobbies, volunteering, or social activities.

Case 2 Continued States at visit, “I feel like my body is falling apart. I hurt all over.” Pain is 6/10 at best, 10/10 at worse, 8/10 most of the time. Exam: Appears tearful and depressed. Moves slowly. Diffusely tender to palpation over lower back and left leg. MAPS shows no other prescribers Urine tox shows prescribed medications

What is the strongest indication to change his regimen? A) Total daily methadone dose of 240 mg/day B) 8/10 pain most of the time C) Prior history of drug abuse D) Signs of depression E) Low level of function

What is the strongest indication to change his regimen? A) Total daily methadone dose of 240 mg/day B) 8/10 pain most of the time C) Prior history of drug abuse D) Signs of depression E) Low level of function

Benefits must outweigh risks! Patient is on a massive dose of methadone; maximum UM recommended dose 40 mg/day! Diffuse pain suggests opiate-induced hyperalgesia Despite extraordinary opiate doses, patient is almost completely nonfunctional.

Ok, but now what? Have an honest talk with the patient about risk and benefits from treatment Be clear that intent is not punitive Plan a gradual taper, with frequent follow- up Set targets for increasing activities and socialization. Mental health interventions

Case 3 48 y/o F with chronic low back pain x 15 years following laminectomy, and fibromyalgia x 3 years, on methadone 10 mg TID, complains of worsening pain in back, as well as aching in arms, legs, and all of her joints. Symptoms worsening gradually over the past year. No fevers, sweats, or weight loss.

Exam shows diffuse lumbar tenderness to palpation, tenderness of muscles, and classic fibromyalgia “trigger points”. Normal strength, no muscle or joint abnormalities beyond pain, and no objective arthritis. Complete rheumatologic workup including ANA, RF, ESR, CRP, TSH, and CK are entirely normal.

At this point, which is most likely to improve this patient’s pain? A)Increase methadone dose B)Decrease methadone dose C)Start duloxetine D)Start nortriptyline E)Start gabapentin

At this point, which is most likely to improve this patient’s pain? A)Increase methadone dose B)Decrease methadone dose C)Start duloxetine D)Start nortriptyline E)Start gabapentin

Opioid-Induced Hyperalgesia (OIH): Common and under-recognized long term complication of opioid use Mechanisms unclear Risk increases with dose and duration May be confused with tolerance May be focal, or can resemble fibromyalgia; ask whether on opioids at time of fibro dx

Suspect OIH if: Worsening pain complaints in absence of change in underlying disease Fibromyalgia diagnosis or symptoms that develop after start of opioid therapy High dose opioids Long duration of opioid use Poor pain control on opioid therapy Physical evidence of hyperalgesia

Management: Taper or discontinue opioids Consider switching to methadone Consider switching to buprenorphine

Take Home Points Don’t kiss on the first date Avoid sedatives in chronic pain Avoid medication duplication Learn opioid equivalents Limit dosages to <120 MED Assess functional benefits Recognize when opioids fail

Useful Reading UM PAIN / OPIOID GUIDELINEUM PAIN / OPIOID GUIDELINE med.umich.edu > For Health Professionals > Clinical Guidelines WA INTERAGENY GUIDELINE on Opioid Dosing for Chronic Non-Cancer PainWA INTERAGENY GUIDELINE on Opioid Dosing for Chronic Non-Cancer Pain dline%5B1%5D.pdf or “Google” it A COMPREHENSIVE REVIEW OF OPIOID-INDUCED HYPERALGESIA. Lee et al., Pain Physician 14: (2011).A COMPREHENSIVE REVIEW OF OPIOID-INDUCED HYPERALGESIA. Lee et al., Pain Physician 14: (2011).